Quoin Pharmaceuticals
QNRX
4 hedge funds and large institutions have $462K invested in Quoin Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
19% less capital invested
Capital invested by funds: $573K → $462K (-$111K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$158K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$15K |
| 2 |
SIGI
Susquehanna International Group (Ireland)
Dublin,
Ireland
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $171K | +$158K | +2 | +200% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $124K | – | – | – |
|
|
WS
3
Wedbush Securities
Los Angeles,
California
| $59K | – | – | – |
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $50K | – | – | – |
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $25K | – | – | – |
|
6
Citadel Advisors
Miami,
Florida
| $15K | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $7K | – | – | – |
|
|
RJFSA
8
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $6K | – | – | – |
|
9
Citigroup
New York
| $5K | – | – | – |
|
|
SIGI
10
Susquehanna International Group (Ireland)
Dublin,
Ireland
| – | -$12K | – | – |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$15K | – | – |
|
QNRX Hedge Fund Activity: Q2 2019 in Review
4 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q2 2019, worth a combined $462K — down 19% from $573K a quarter earlier.
Fund positioning in QNRX was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $158K. The largest seller was Two Sigma Securities, cutting an estimated $15K.
- 4 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $462K of Quoin Pharmaceuticals stock for Q2 2019, down 19% quarter-over-quarter.
- 0 funds opened new Quoin Pharmaceuticals positions in Q2 2019 and 0 closed out.
- The largest Quoin Pharmaceuticals buyer in Q2 2019 was Renaissance Technologies, an estimated $158K added.
- The largest Quoin Pharmaceuticals seller in Q2 2019 was Two Sigma Securities, an estimated $15K sold.
Based on aggregated 13F filings for Q2 2019.